Sweden: IK Investment to acquire Mabtech

Erik Ingemarsson, partner, Investment Partners

IK Investment Partners is to acquire Sweden’s Mabtech, a specialist in immune monitoring. Merieux Equity Partners has also taken a minority stake. Financial terms have not been disclosed. “The deal team has followed the company for several years and we understood this was a unique opportunity to acquire a global leader in a niche market…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »